Brett Sandercock - 19 Aug 2021 Form 4 Insider Report for RESMED INC (RMD)

Reporting relationship: Chief Financial Officer
Issuer ticker: RMD
Reported as of: 19 Aug 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Aug 2021, 12:05:42 UTC
Prior SEC filing: 11 Aug 2021
Next SEC filing: 23 Aug 2021
Source filing: View source filing
Reporting owner signature: Brett Sandercock, Chief Financial Officer

Key filing fact

Brett Sandercock filed Form 4 for RESMED INC (RMD) on 20 Aug 2021.

Key facts

This page summarizes Brett Sandercock's Form 4 filing for RESMED INC (RMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 Aug 2021, 12:05.

Change

Previous filing in this sequence was filed on 11 Aug 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMD transaction

ResMed Common Stock

Award

Transaction value: $0
Shares: +4,784
Change %: +5.6%
Price: $0.000000
Shares after: 89,786
Date: 19 Aug 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on August 19, 2021, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.